Abstract
Background
It has already been suggested that high abnormal blood lipid concentration is associated with hyperglycaemia. However, no data is available about the roles of triglycerides (TG) and total cholesterol (TC) levels in diabetes. Here, for the first time we investigated the roles of TG and TC levels, gender and abdominal fat in the development of newly diagnosed diabetes in China.
Materials and Methods
Two population-based cross-sectional surveys were conducted from 2006 to 2009 in Qingdao, China. Newly diagnosed diabetes was defined according to FPG and/or 2 h PG criteria. The associations between diabetes and TG, and TC levels were assessed by multi-variable logistic regression models.
Results
As compared with non-diabetes, the odds ratio[(95% confidence intervals), OR(95% CI)] for diabetes corresponding to hypertriglyceridemia (HTG) were 1.54 (1.01, 2.35) in men and 2.02 (1.49, 3.10) in women for TG and accompany with Hypercholesterolemia (HTC) 2.93 (1.97, 4.37) and 2.13 (1.49, 3.05) for TC, when both were fitted simultaneously in the model adjusting for age, geographic division, marital status, school years, family history of diabetes, monthly income, systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), high density lipoprotein cholesterol (HDL-C), alanine amino transferase (ALT) and gamma-glutamyltransferase (GGT).
Conclusions
HTG in both gender, borderline high TC and HTC in men were an independent risk factor for diabetes in this Chinese population, however, HTC was mediated through abdominal fat for diabetes in women. Our findings may help to enhance the current knowledge of diabetes patho-physiology, and the associations between TG, TC level and diabetes is also clinically informative.
Keywords: triglycerides, total cholesterol, newly diagnosed, adult onset diabetes, waist circumference
INTRODUCTION
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia over a prolonged period [1]. It is estimated that a total of415 million people live with diabetes in the world [2] and almost 193 million people have undiagnosed diabetes worldwide [3].Prevalence of diabetes is continually increasing in the world particularly in China [4, 5], mostly due to obesity, overweight, physical inactivity and unhealthy diet.
Triglycerides (TG) are the main constituents of body fat in humans [6], and irresponsible for the bidirectional transference of adipose fat and blood glucose from the liver. Total cholesterol (TC) is an important constituent (30%) of all human cell membranes, builds and maintains membranes and modulates membrane fluidity over the range of physiological processes. Different studies have demonstrated that elevated TG and TC is an independent risk factor of cardiovascular disorders [7–10]. It is generally known that diabetes was often accompanied by several potential risk factors of cardiovascular events, such as elevated TG [11, 12] and TC [13]. During last few decades, mean TG levels have increased in concert with the growing epidemic of diabetes mellitus and obesity, however, mean TC levels have decreased in America [14, 15].
In 2007, the prevalence rate of diabetes was 9.7% in China [5], which was almost two times higher than 2000–2001 (5.4%) estimates [4]. A large Chinese national survey reported in 2010 has suggested that type 2 diabetes has become a seriously public health threat in China. C-reactive protein (CRP) which is a nonspecific biomarker of acute inflammation and is normally produced in the liver. There is increasing evidence showing that elevated C-reactive protein and gamma glutamyltransferase are the potential risk factors for diabetes [16]. However, to the best our knowledge, no study has reported an association between TG and TC levels with diabetes in the world, particularly in China. Therefore, the present study was designed to investigate the associations between TG and TC concentration and the prevalence of diabetes in a Chinese population living in Qingdao, China.
RESULTS
In this study, a total of 5012 participants were recruited, among them 2061 were men (41.1%) and 2951 were women (58.9%). The mean age of the 5012 participants was 50.7 (50.4–51.0) years with a range of 35–74 years. The mean values of FPG, 2 h PG, and HbA1c were 5.70 (5.67, 5.73), 7.34 (7.25, 7.42), and 4.46 (4.43, 4.49), respectively. The mean values of TG and TC were 1.40 (1.37, 1.43) and 5.31 (5.28, 5.34), respectively. The baseline characteristics of the participants have been shown in Table 1.
Table 1. Baseline characteristics of participants according to glucose.
| Men | women | |||
|---|---|---|---|---|
| Non-diabetes | diabetes | Non-diabetes | diabetes | |
| Number (%) | 1793 (87.0) | 268 (13.0) | 2607 (88.3) | 344 (11.7) |
| Age (years) | 50.3 (49.8, 50.8) | 55.2 (53.9, 56.5)ǂ | 49.7 (49.3, 50.1) | 56.8 (55.7, 57.9)ǂ |
| Urban living | 587 (32.7) | 107 (39.9)* | 1436 (55.1) | 178 (57.1) |
| Married, n (%) | 1706 (96.4) | 248 (93.9) | 2448 (95.0) | 298 (88.4)ǂ |
| School years > 9 (%) | 673 (37.7) | 89 (33.6) | 836 (32.2) | 60 (17.5)ǂ |
| Current Smoking (yes, %) | 924 (51.7) | 144 (54.1) | 30 (1.2) | 7 (2.1) |
| Alcohol-drinking (yes, %) | 788 (44.1) | 134 (50.2) | 40 (1.5) | 2 (0.6) |
| Family history of diabetes (yes, %) | 245 (14.6) | 62 (24.0)ǂ | 473 (19.1) | 79 (23.7)* |
| Income (CNY/month), n (%) | ||||
| ≤ 599 | 595 (34.2) | 95 (36.4) | 1188 (47.4) | 174 (52.3)* |
| 600–1999 | 847 (48.7) | 135 (51.7) | 1179 (47.0) | 155 (46.5) |
| ≥ 2000 | 292 (17.1) | 31 (11.9) | 141 (5.6) | 4 (1.2) |
| Body mass index (kg/m2) | 25.1 (25.0, 25.3) | 26.0 (25.6, 26.4)ǂ | 25.4 (25.3, 25.5) | 26.7 (26.3, 27.0)ǂ |
| Waist circumference (cm) | 86.2 (85.8, 86.7) | 89.0 (87.8, 90.2)ǂ | 82.0 (81.7, 82.4) | 85.3 (84.3, 86.3)ǂ |
| Systolic blood pressure (mmHg) | 133.3 (132.4, 134.1) | 138.7 (136.5, 140.9)ǂ | 131.0 (130.2, 131.8) | 138.5 (136.3, 140.7)ǂ |
| Diastolic blood pressure (mmHg) | 86.1 (85.6, 86.7) | 88.0 (86.5, 89.4)* | 83.2 (82.8, 83.6) | 85.9(84.7, 87.2)ǂ |
| Fasting plasma glucose (mmol/L) | 5.48 (5.42, 5.53) | 7.59 (7.44, 7.74)ǂ | 5.46 (5.43, 5.49) | 7.26 (7.17, 7.36)ǂ |
| 2 hours post-load plasma glucose (mmol/L) | 6.42 (6.30, 6.53) | 12.16 (11.86, 12.46)ǂ | 6.75 (6.67, 6.83) | 12.80 (12.57, 13.03)ǂ |
| Glycatedhaemoglobin (%) | 4.39 (4.34, 4.43) | 5.12 (5.00, 5.23)ǂ | 4.37 (4.33, 4.40) | 5.06 (4.96, 5.17)ǂ |
| High density lipoprotein cholesterol (mmol/L) | 1.63 (1.61, 1.65) | 1.63 (1.57, 1.68) | 1.67 (1.65, 1.68) | 1.59 (1.55, 1.63)ǂ |
| Alanine amino transferase (U/L) | 16.96 (16.22, 17.62) | 21.45 (19.63, 23.27)ǂ | 14.34 (13.87, 14.81) | 16.36 (15.04, 17.69)* |
| Gamma-glutamyltransferase (U/L) | 36.22 (32.88, 38.56) | 56.09 (50.00, 62.18)ǂ | 18.52 (17.84, 19.20) | 26.47 (24.55, 28.38)ǂ |
| Triglycerides (mmol/L) | 1.40 (1.35, 1.46) | 1.93 (1.80, 2.07)ǂ | 1.30 (1.25, 1.31) | 1.88 (1.73, 2.03)ǂ |
| Normal TG | 1365 (76.1) | 168 (62.7)ǂ | 2070 (79.4) | 195 (56.7)ǂ |
| Borderline high TG | 209 (11.7) | 47 (17.5) | 326 (12.5) | 66 (19.2) |
| Hypertriglyceridemia | 219 (12.2) | 53 (19.8) | 211 (8.1) | 83 (24.1) |
| Total cholesterol (mmol/L) | 5.23 (5.18, 5.27) | 5.67 (5.55, 5.79)ǂ | 5.29 (5.25, 5.32) | 5.62 (5.51, 5.72)ǂ |
| Normal TC | 925 (51.6) | 85 (31.7)ǂ | 1288 (49.4) | 106 (30.8) |
| Borderline high TC | 619 (34.5) | 102 (38.1) | 875 (33.6) | 110 (32.0) |
| Hypercholesterolemia | 249 (13.9) | 81 (30.2) | 444 (17.0) | 128 (37.2) |
Data are age-adjusted mean (95% confidence interval) or n (%) as indicated. *P < 0.05, ǂ< 0.001, non-diabetes versus diabetes within the same gender
The prevalence of newly diagnosed diabetes was 13.0% in men and 11.7% in women. Compared with non-diabetes, those individuals with newly diagnosed diabetes were older, more obese, and have higher levels of systolic blood pressure (SBP), diastolic blood pressure (DBP), ALT, TG and TC. Family history of diabetes was more common in individuals with diabetes than in those without diabetes. However, current smoking and alcohol drinking appeared to have no influence on diabetes and non-diabetes in either group.
The correlation (R2) for TG and TC in association with glucose and HbA1c has been given in Table 2. The levels of serum TG and TC has an independent positive correlation with FPG, 2 h PG, and HbA1c in the study population (Table 2). The OR of HTG in newly diagnosed diabetes was significantly higher (P < 0.001) than those with normal TG in all models. In this study, there was a significantly higher (P < 0.001) association among borderline high TG and diabetes in men in model 1 and 2 and in women in model 1, 2 and 3, but difference was not significant (P > 0.005) when both TG and TC were included in the same model (Table 2). OR value for diabetes was significantly higher (P < 0.001) for HTC in men and borderline high TG and HTC in women but difference was significantly higher (P < 0.001) when both TG and TC were included in the same model. There was also a significant interaction of WC with TG (P < 0.001 in men and women) and TC (P < 0.001 in men and women) in men and women (Table 3), and hence a stratified analysis by the WC category was further performed to investigate the association between the TG, TC and newly diagnosed diabetes. The result revealed that there was significantly higher (P < 0.001) association between HTG and diabetes in men, but the difference was non-significant (P > 0.005) after further adjustment for TG. There was no significant (P > 0.005) association between borderline high TG and diabetes in men of normal WC. The significant association between HTG and diabetes was evaluated in women of normal WC, and no significant association (P > 0.005) was found after further adjustment models. A significant association between HTC and diabetes was observed in obese women, however, not in women of normal WC (Table 3). Other results were similar to those of men and women without WC category.
Table 2. Standard β coefficients and R square (R2) for triglycerides and total cholesterol in association with fasting plasma glucose, 2 h post-load plasma glucose and glycatedhaemoglobin (%).
| Fasting plasma glucose | 2 h post-load plasma glucose | Glycatedhaemoglobin | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Standard βcoefficients |
R2 | P | Standard βcoefficients | R2 | P | Standard βcoefficients |
R2 | P | |
| Men | |||||||||
| Triglycerides (mmol/L) | 0.124 | 0.101 | < 0.001 | 0.109 | 0.102 | < 0.001 | 0.119 | 0.135 | < 0.001 |
| Total cholesterol (mmol/L) | 0.173 | 0.114 | < 0.001 | 0.088 | 0.100 | < 0.001 | 0.047 | 0.126 | < 0.001 |
| Women | |||||||||
| Triglycerides (mmol/L) | 0.127 | 0.130 | < 0.001 | 0.134 | 0.153 | < 0.001 | 0.100 | 0.198 | < 0.001 |
| Total cholesterol (mmol/L) | 0.219 | 0.153 | < 0.001 | 0.113 | 0.148 | < 0.001 | 0.076 | 0.195 | < 0.001 |
| All | |||||||||
| Triglycerides (mmol/L) | 0.120 | 0.105 | < 0.001 | 0.123 | 0.120 | < 0.001 | 0.114 | 0.166 | < 0.001 |
| Total cholesterol (mmol/L) | 0.193 | 0.123 | < 0.001 | 0.109 | 0.117 | < 0.001 | 0.068 | 0.159 | < 0.001 |
Adjusted for age, geographic division, marital status, school years, family history of diabetes, monthly income, waist circumference, systolic blood pressure, diastolic blood pressure, high density lipoprotein cholesterol, alanine amino transferase and gamma-glutamyltransferase.
Table 3. Odds ratio (95% confidence interval) for newly diagnosed diabetes in relation to triglycerides and total cholesterol concentration.
| Model 1 | Model 2 | Model 3 | Model 4 | ||
|---|---|---|---|---|---|
| Men | |||||
| Normal WC | |||||
| TG | |||||
| Normal TG | 750 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TG | 69 | 1.19 (0.47, 2.99) | 1.19 (0.47, 3.00) | 1.03 (0.40, 2.67) | 0.88 (0.33, 2.31) |
| Hypertriglyceridemia | 50 | 2.75 (1.26, 6.02) | 2.90 (1.31, 6.43) | 2.63 (1.09, 6.33) | 1.94 (0.77, 4.86) |
| TC | |||||
| Normal TC | 462 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TC | 280 | 1.91 (1.07, 3.40) | 1.92 (1.08, 3.41) | 2.17 (1.18, 3.99) | 2.09 (1.14, 3.87) |
| Hypercholesterolemia | 127 | 4.45 (2.39, 8.30) | 4.48 (2.40, 8.36) | 5.23 (2.60, 10.56) | 4.88 (2.40, 9.95) |
| Abdominal obesity | |||||
| TG | |||||
| Normal TG | 783 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TG | 187 | 1.64 (1.05, 2.56) | 1.62 (1.04, 2.54) | 1.54 (0.96, 2.45) | 1.41 (0.88, 2.26) |
| Hypertriglyceridemia | 222 | 1.90 (1.22, 2.95) | 1.82 (1.17, 2.84) | 1.58 (0.98, 2.57) | 1.38 (0.85, 2.26) |
| TC | |||||
| Normal TC | 548 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TC | 441 | 1.61 (1.08, 2.40) | 1.61 (1.08, 2.42) | 1.57 (1.03, 2.38) | 1.50 (0.99, 2.29) |
| Hypercholesterolemia | 203 | 2.65 (1.68, 4.16) | 2.62 (1.66, 4.13) | 2.56 (1.58, 4.16) | 2.40 (1.47, 3.91) |
| All | |||||
| TG | |||||
| Normal TG | 1533 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TG | 256 | 1.64 (1.11, 2.44) | 1.56 (1.04, 2.32) | 1.49 (0.98, 2.25) | 1.34 (0.88, 2.04) |
| Hypertriglyceridemia | 272 | 2.19 (1.51, 3.20) | 2.01 (1.37, 2.96) | 1.81 (1.19, 2.74) | 1.52 (0.99, 2.33) |
| TC | |||||
| Normal TC | 1010 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TC | 721 | 1.69 (1.22, 2.34) | 1.66 (1.19, 2.30) | 1.65 (1.18, 2.32) | 1.59 (1.13, 2.24) |
| Hypercholesterolemia | 330 | 3.16 (2.20, 4.54) | 3.07 (2.13, 4.43) | 3.09 (2.08, 4.58) | 2.89 (1.94, 4.31) |
| Women | |||||
| Normal WC | |||||
| TG | - | ||||
| Normal TG | 1026 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TG | 93 | 1.53 (0.67, 3.52) | 1.43 (0.61, 3.31) | 1.29 (0.54, 3.09) | 1.34 (0.55, 3.21) |
| Hypertriglyceridemia | 55 | 2.73 (1.19, 6.26) | 2.63 (1.14, 6.03) | 2.11 (0.87, 5.08) | 2.28 (0.93, 5.59) |
| TC | |||||
| Normal TC | 650 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TC | 362 | 0.90 (0.49, 1.67) | 0.89 (0.48, 1.65) | 0.90 (0.47, 1.70) | 0.85 (0.44, 1.63) |
| Hypercholesterolemia | 162 | 0.87 (0.41, 1.84) | 0.87 (0.41, 1.84) | 0.80 (0.36, 1.77) | 0.70 (0.31, 1.59) |
| Abdominal obesity | |||||
| TG | |||||
| Normal TG | 1239 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TG | 299 | 1.62 (1.13, 2.33) | 1.55 (1.08, 2.23) | 1.57 (1.08, 2.29) | 1.26 (0.85, 1.87) |
| Hypertriglyceridemia | 239 | 2.79 (1.94, 4.00) | 2.77 (1.92, 3.98) | 2.61 (1.78, 3.84) | 2.01 (1.34, 3.02) |
| TC | |||||
| Normal TC | 744 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TC | 623 | 1.37 (0.95, 1.97) | 1.37 (0.95, 1.98) | 1.48 (1.01, 2.16) | 1.33 (0.91, 1.96) |
| Hypercholesterolemia | 410 | 2.99 (2.07, 4.30) | 3.05 (2.11, 4.40) | 3.43 (2.30, 5.13) | 2.85 (1.88, 4.33) |
| All | |||||
| TG | |||||
| Normal TG | 2265 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TG | 392 | 1.68 (1.21, 2.34) | 1.52 (1.09, 2.12) | 1.51 (1.07, 2.13) | 1.30 (0.91, 1.85) |
| Hypertriglyceridemia | 294 | 3.01 (2.17, 4.19) | 2.82 (2.03, 3.93) | 2.59 (1.83, 3.68) | 2.15 (1.49, 3.10) |
| TC | |||||
| Normal TC | 1394 | 1.00 | 1.00 | 1.00 | 1.00 |
| Borderline high TC | 985 | 1.23 (0.90, 1.68) | 1.21 (0.89, 1.66) | 1.29 (0.93, 1.78) | 1.17 (0.84, 1.62) |
| Hypercholesterolemia | 572 | 2.40 (1.75, 3.30) | 2.40 (1.74, 3.30) | 2.58 (1.83, 3.64) | 2.14 (1.49, 3.06) |
Model 1: adjusted for age, geographic division, marital status, school years, family history of diabetes, monthly income, systolic blood pressure, diastolic blood pressure.
Model 2: Model 1+ waist circumference
Model 3: Model 2 + high density lipoprotein cholesterol, alanine amino transferase and gamma-glutamyltransferase.
Model 4: TG and TC fitted simultaneously into the Model 3.
DISCUSSION
In this population-based cross-sectional study, we found that HTG and HTC were positively associated with newly diagnosed diabetes in both genders. HTC was significantly associated with newly diagnosed diabetes only in obese women, while it is a potential independent risk factor for diabetes in men of all WC categories. While, borderline high TG was also positively associated with newly diagnosed diabetes in both genders, but difference become non significance after further adjustment for TG. Borderline high TC was also positively associated with newly diagnosed diabetes in men, but not in women.
Previously reported studies had suggested that level of TG in serum was positively associated with diabetes. Moreover, it has also been shown that increased serum TG levels over time enhanced the risk of developing diabetes in various populations [17–22], these observation are consistent with our results. Many studies have reported that abdominal fatis also a primary risk factor for diabetes in the world. In the Norwegian cohort study has indicated that clinical models such as BMI,men and women aged 40–45 years; and TG is the important predictors of diabetes [23]. However, our results showed that the individual’s with HTG had a higher OR of diabetes as compared with those with normal TG in both gender, but there were non-significant differences for TG between men and women with normal WC after further adjustment. The association among impaired TG, abdominal obese and diabetes is more frequent, whereas the potential patho-physiological mechanisms are very complicated and only partially understood. Previously reported study has confirmed that abdominal obese release excessive free fatty acids, which are transported to the liver and pancreas and reduced response to insulin signaling (i.e. insulin resistance) [24]. The surplus fatty acids are restructured into triglycerides in the liver and stored into hepatocytes [25].
There is less research available on the association of TC and diabetes. In the Australian Diabetes, Obesity and Lifestyle Study and the San Antonio Family Heart Study [26], TC was strongly associated with diabetes after multivariate analysis. Results from the Multiple Risk Factor Intervention Trial study indicated that people with elevated TC has 2-flod high risk of coronary mortality in the diabetes patients as compared with controls [27, 28]. Further, there was a relationship between high total cholesterol levels and abnormalities in fasting glucose metabolism only in Diabetic patients with elevated waist circumference. In this study, we also found that the higher TC level was positively associated with pre-diabetes and diabetes in both gender, especially in women with high abdominal fat. This may be explained by the individuals with abdominal obese, abnormally in response to 2 h PG, associated with high TC level. Those subjects were characterized by high waist circumference, a poor glycemic profile and a lipid disorder (i.e. high TG level and/or high TC level). One possible interpretation of this pattern is that the excessive TC may increase dimerization of the enzyme NO synthase, which down-regulates the activity of glucokinase, thereby reducing the intra-cytoplasmic metabolism of glucose [29].
The strength of our study was the large number of subjects, the detailed analysis of the role of TG, TC level with diabetes. The application of multiple statistical models with different populations and different types of variables to evaluate the robustness of the relationship between TG, TC level and diabetes are additional strengths of this study. Third leading strength was that all newly diabetes individuals were diagnosed according to fasting plasma glucose and/or 2 h post-load plasma glucose. However, there were several limitations in this study. First, the current study was a cross-sectional study. Second, only TG and TC were performed in the current study, and the possible association of lipid disorder with newly diagnosed diabetes could not be accurately explored.
MATERIALS AND METHODS
Study population
A population-based cross-sectional diabetes survey was conducted in Qingdao in 2006 and 2009, separately. Both surveys targeted the population of three urban districts (Shinan, Shibei and Sifang) and three rural districts (Huangdao, Jiaonan and Jimo). A stratified, random cluster sampling method was used to recruit a general populationrepresentativeof 12 100 citizens (6100 in 2006 and 6000 in 2009) aged 35–74 years who have lived in Qingdao city for at least 5 years. A total of 10 465 individuals (5355 in 2006 and 5110 in 2009)were initially enrolled in this study with a response rate of 87.8% in 2006 and 85.2% in 2009, respectively (Figure 1). In this study we had used a strict inclusion criteria: 1) newly diagnosed diabetes based on fasting plasma glucose (FPG) and 2 h post-load plasma glucose (2 h PG); 2) no data missing for body mass index (BMI), waist circumference (WC), glycatedhaemoglobin (HbA1c), triglycerides, and total cholesterol level. A total of 5012 (2061 men and 2951 women) individuals were included who met the strict inclusion criteria for the analysis. Informed consent was collected from all participants. This study was approved by the local ethics committee at Qingdao Municipal Health and Family planning commission.
Figure 1. Flow chart of the participants included in the cross sectional analysis.
All eligible individuals were request to visit at the local community center, and the object of study was again explained individually. All participants were interviewed by trained interviewers using a standardized questionnaire to elicit information on socio-demographic risk factors. Marital status was classified as married/cohabiting or single/divorced/widowed). Smoking status was defined as current smokers (smoking daily regardless of the amount and type of smoking) and non-smokers (including ex-smoking, smoking now and then, not smoking at all). Alcohol-drinking status was categorized into current drinkers (drinking frequently regardless of the amount and type of alcohol) and non-drinkers (including ex-drinkers, drinking now and then, not drinking at all). Educational attainment was c7ategorized into 2 groups of school years ≤ 9y and > 9y. Personal monthly income was categorized into ≤ 599 Chinese Yuan (CNY), 600–1999 CNY, and ≥ 2000 CNY. Family history of diabetes was defined as having at least one family member (including parents, sibling and/or offspring’s) diagnosed as diabetes, without regarding the types of diabetes (Table 1).
Participant’s height and weight were measured without shoe and wearing light clothes using digital scales and a portable stadiometer, and body mass index was calculated as weight in kilograms dividing by height in meters squared (kg/m2). Waist circumference was measured at the middle of the rib cage and the iliac crest to the nearest 0.1 cm. Three consecutive blood pressure readings, at least 30sec apart, were taken from the upper right arm of the seated participants, and the mean value was used in subsequent data analysis.
Blood samples were collected in locally community centers, and transported in a dark box with ice to the laboratory and stored at -80 °C freezer. All blood samples were analyzed in the central laboratory of Qingdao Endocrinology and Diabetes Hospital. Standard 2 h 75g oral glucose tolerance tests (OGTT) were administrated in all participants without a prior history of diabetes. Plasma glucose was measured using glucose oxidase method. Glycatedhaemoglobin (HbA1c) was measured using an immunoturbidimetry method (Tina-qu.a A1C HIT 917 large; Roche Diagnostics). The HbA1c concentration was calculated by using the formula provided by Roche Diagnostics: [calculated HbA1c (%) = 0.81 × HbA1c (test result) + 2.39] to match the values with those found in a conventional high performance liquid chromatography (HPLC) method. Fasting serum triglycerides (TG), total cholesterol (TC) and high-density lipoprotein cholesterol (HLD-C) were measured using enzymatic methods. Serum gamma-glutamyltransferase (GGT) and alanine aminotransferase (ALT) were determined by an International Federation of Clinical Chemistry (IFCC) method.
Classification of individuals
Individuals with previously diagnosed diabetes, who reported a history of diabetes and were under treatment with either insulin or oral anti-diabetic, were excluded from the analysis. Newly diagnosed diabetes was determined if FPG ≥ 7.0 mmol/l and/or 2 h PG ≥ 11.1 mmol/l according to the 2006World Health Organization (WHO)/International Diabetes Federation (IDF) standards [30]. According to the most recent guideline from Chinese Heart Association [31], TG and TC levels were considered normal if they were TG < 150 mg/dl and TC < 200 mg/dl, borderline high if they were 150–199 mg/dl and 200–240 mg/dl, high if they were ≥ 200 mg/dl [hypertriglyceridemia (HTG)] and ≥ 240 mg/dl [Hypercholesterolemia (HTC)]. Central obesity was defined as having waist circumference ≥ 90 cm for Chinese men and ≥ 80 cm for Chinese women [32].
Statistical analysis
The Chi-squared test was used to compare the difference in prevalence between different glucose categories. Age-adjusted mean values and the differences of continuous variables were calculated using the general linear model in different glucose categories. The linear regression analysis was used to investigate the linear association of TG and TC with plasma glucose and HbA1c, and multivariable logistic regression analysis was used to estimate the odds ratio (OR) and 95% confidence intervals (95% CI) for the prevalence of diabetes with serum TG and TC levels in men and women. All statistical tests were two-sided; P values < 0.05 were considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics 18.0 (SPSS, Chicago, IL).
CONCLUSIONS
The elevated TG and TC level have highlighted a strong positive association with newly diagnosed diabetes. Additionally, borderline high TC in men and HTC in addition to being high waist circumference had a highly detrimental effect on the presence of diabetes patients in this study population. Our findings may help to enhance the current knowledge of diabetes patho-physiology, and the associations between diabetes and TG and TC level. Additionally, a future large-scale, multi-population-based studyhas been planned to further investigate the relationship between hyperglycemia and the levels of serum TC and TG.
Acknowledgments
We also thank the participants, primary care doctors, and nurses who participated in this survey.
Abbreviations
- ALT
Alanine amino transferase
- BMI
Body mass index
- CI
Confidence intervals
- DBP
Diastolic blood pressure
- FPG
Fasting plasma glucose
- GGT
Gamma-glutamyltransferase
- HbA1c
Glycatedhaemoglobin
- HTC
Hypercholesterolemia
- HTG
Hypertriglyceridemia
- IDF
International Diabetes Federation
- IFCC
International Federation of Clinical Chemistry
- OR
Odds ratio
- OGTT
2 h 75g oral glucose tolerance tests
- SBP
Systolic blood pressure
- TC
TotalCholesterol
- TG
Triglycerides
- WC
waist circumference
- WHO
World Health Organization
- 2 h PG
2-hour plasma glucose
Availability of data and materials
The aggregate data supporting findings contained within this manuscript will be shared upon request submitted to the corresponding author. Identifying patient data will not be shared.
Author contributions
ZB, JC, JS and AM were the primary authors and leading investigators. JC, ZB, WW, HX and QQcarried out the experiments, analyzed experimental results. ZB, JC andYS wrote the manuscript.
CONFLICTS OF INTEREST
All authors declare they have no actual or potential conflicts of interests.
FUNDING
This study was supported by research grants from Qingdao Diabetes Prevention Program and World Diabetes Foundation [WDF05–108 and WDF07–308]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
REFERENCES
- 1.World Health Organization Archived from the original on 31 March 2014. Retrieved 4 April 2014.
- 2.IDF. International Diabetes Federation p13. Retrieved 21 Mar 2016.
- 3.International Diabetes Federation IDF Diabetes Atlas-7th Edition. 2015 http://www.diabetesatlas.org/ [PubMed]
- 4.Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, Mo J, Whelton PK, He J, InterASIA Collaborative Group Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA) Diabetologia. 2003;46:1190–98. doi: 10.1007/s00125-003-1167-8. [DOI] [PubMed] [Google Scholar]
- 5.Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, et al. China National Diabetes and Metabolic Disorders Study Group Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101. doi: 10.1056/NEJMoa0908292. [DOI] [PubMed] [Google Scholar]
- 6.Nelson DL, Cox MM. Lehninger, Principles of Biochemistry. 3rd ed. New York: Worth Publishing; 2000. ISBN: 1–57259–153–6. [Google Scholar]
- 7.Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol. 2011;107:891–97. doi: 10.1016/j.amjcard.2010.11.008. [DOI] [PubMed] [Google Scholar]
- 8.Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B–12B. doi: 10.1016/s0002-9149(98)00031-9. [DOI] [PubMed] [Google Scholar]
- 9.Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309–16. doi: 10.1001/jama.298.3.309. [DOI] [PubMed] [Google Scholar]
- 10.Nagasawa SY, Okamura T, Iso H, Tamakoshi A, Yamada M, Watanabe M, Murakami Y, Miura K, Ueshima H, Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan. J Am Heart Assoc. 2012;1:e001974. doi: 10.1161/JAHA.112.001974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kompoti M, Mariolis A, Alevizos A, Kyrazis I, Protopsaltis I, Dimou E, Lentzas I, Levisianou D, Gova A, Melidonis A. Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes. Cardiovasc Diabetol. 2006;5:21. doi: 10.1186/1475-2840-5-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Riediger ND, Clark K, Lukianchuk V, Roulette J, Bruce S. Fasting triglycerides as a predictor of incident diabetes, insulin resistance and β-cell function in a Canadian First Nation. Int J Circumpolar Health. 2017;76:1310444. doi: 10.1080/22423982.2017.1310444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rhee EJ, Han K, Ko SH, Ko KS, Lee WY. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: A nationwide population-based study. PLoS One. 2017;12:e0176615. doi: 10.1371/journal.pone.0176615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005;294:1773–81. doi: 10.1001/jama.294.14.1773. [DOI] [PubMed] [Google Scholar]
- 15.Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235–41. doi: 10.1001/jama.2009.2014. [DOI] [PubMed] [Google Scholar]
- 16.Ren J, Pang ZC, Gao WG, Nan HR, Wang SJ, Zhang L, Qiao Q. C-reactive protein and gamma-glutamyltransferase concentrations in relation to the prevalence of type 2 diabetes diagnosed by glucose or HbA1c criteria in Chinese adults in Qingdao, China. Exp Diabetes Res. 2010;2010:761715. doi: 10.1155/2010/761715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36:232–40. doi: 10.1016/j.arcmed.2005.01.005. [DOI] [PubMed] [Google Scholar]
- 18.Dotevall A, Johansson S, Wilhelmsen L, Rosengren A. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med. 2004;21:615–22. doi: 10.1111/j.1464-5491.2004.01189.x. [DOI] [PubMed] [Google Scholar]
- 19.Hjellvik V, Sakshaug S, Strøm H. Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women. Clin Epidemiol. 2012;4:213–24. doi: 10.2147/CLEP.S31830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB., Sr Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007;167:1068–74. doi: 10.1001/archinte.167.10.1068. [DOI] [PubMed] [Google Scholar]
- 21.Tirosh A, Shai I, Bitzur R, Kochba I, Tekes-Manova D, Israeli E, Shochat T, Rudich A. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care. 2008;31:2032–37. doi: 10.2337/dc08-0825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Taskinen MR. Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol. 1995;6:153–60. doi: 10.1097/00041433-199506000-00007. [DOI] [PubMed] [Google Scholar]
- 23.Miselli MA, Nora ED, Passaro A, Tomasi F, Zuliani G. Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study. Cardiovasc Diabetol. 2014;13:135. doi: 10.1186/s12933-014-0135-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359–404. doi: 10.1152/physrev.00033.2011. [DOI] [PubMed] [Google Scholar]
- 25.Adiels M, Taskinen MR, Borén J. Fatty liver, insulin resistance, and dyslipidemia. Curr Diab Rep. 2008;8:60–64. doi: 10.1007/s11892-008-0011-4. [DOI] [PubMed] [Google Scholar]
- 26.Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, MacIntosh GL, Almasy L, Comuzzie AG, Mahaney MC, Kowalczyk A, Haviv I, Grantham N, Magliano DJ, et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One. 2013;8:e74341. doi: 10.1371/journal.pone.0074341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Giannini S, Bardini G, Dicembrini I, Monami M, Rotella CM, Mannucci E. Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism. J Clin Lipidol. 2012;6:132–38. doi: 10.1016/j.jacl.2011.09.005. [DOI] [PubMed] [Google Scholar]
- 28.Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–44. doi: 10.2337/diacare.16.2.434. [DOI] [PubMed] [Google Scholar]
- 29.Bardini G, Rotella CM, Giannini S. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications. Rev Diabet Stud. 2012;9:82–93. doi: 10.1900/RDS.2012.9.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.WHO . IDF Consultation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO ⁄International Diabetes Federation Consultation. Geneva: The World Health Organization Document Production Services; 2006. [Google Scholar]
- 31.Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults Guidelines on prevention and treatment of blood lipid abnormality in Chinese adults (Revised in 2016) Chinese Circulation Journal. 2016;31:937–53. [Google Scholar]
- 32.Disease Control . China MoHotPsRo. Chinese guidelines on overweight and obesity prevention and control in adults. Beijing: People' s Medical Publishing House; 2006. [Google Scholar]